Eduardo Vilar-Sánchez
researcherMale0.0Global Dominance: 0.00%
Eduardo Vilar-Sánchez is a Spanish researcher and professor of Clinical Cancer Prevention at the MD Anderson Cancer Center, University of Texas. He led a groundbreaking clinical trial demonstrating the efficacy of the NOUS-209 vaccine in stimulating immune responses in individuals with Lynch syndrome, highlighting its potential in cancer interception.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Eduardo Vilar-Sanchez is the trial leader of Nous-209 and discussed the potential of preventative vaccines for Lynch carriers.
A promising vaccine aims to prevent cancer in people with Lynch syndromeThe Globe and Mail·
Canada· 2026-02-05
Canada· 2026-02-05
Eduardo Vilar-Sánchez is a Spanish researcher who led the study on the NOUS-209 vaccine.
Vacuna para prevenir el cáncer demuestra eficacia en un ensayo clínicoListín Diario – oldest Dominican newspaper, est. 1889·
Dominican Republic· 2026-01-17
Dominican Republic· 2026-01-17
